Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 28, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Market Cap	77	83	99	66	67	104
Market Cap Growth	-10.66%	-15.98%	49.41%	-1.06%	-35.83%	-27.85%
Enterprise Value	76.56	82.53	94.83	70.74	65.12	104.31
Last Close Price	5.53	5.96	7.15	4.85	4.92	7.68
PE Ratio	-	-	21.67	-	-	192.00
Forward PE	-	114.60	119.17	64.10	43.81	42.95
PEG Ratio	-	4.27	4.27	4.27	2.92	2.86
PS Ratio	1.29	1.39	1.73	1.31	1.24	2.11
PB Ratio	19.50	21.01	26.12	-34.65	14.37	11.42
P/TBV Ratio	21.22	22.88	29.68	-	15.49	12.41
P/FCF Ratio	-	-	14.08	-	60.58	25.25
P/OCF Ratio	-	-	13.34	-	16.78	15.98
EV/Sales Ratio	1.29	1.39	1.67	1.41	1.21	2.12
EV/EBITDA Ratio	323.03	348.25	15.31	-	-	46.69
EV/EBIT Ratio	-	-	20.83	-	-	171.85
EV/FCF Ratio	-	-	13.55	-	59.20	25.36
Debt / Equity Ratio	0.74	0.74	1.23	-3.20	1.59	0.92
Debt / EBITDA Ratio	19.04	19.04	0.99	-	-	4.24
Debt / FCF Ratio	-	-	0.87	-	7.82	2.30
Net Debt / Equity Ratio	-0.09	-0.09	-0.98	-2.53	-0.33	0.05
Net Debt / EBITDA Ratio	-1.52	-1.52	-0.59	-0.88	0.51	0.21
Net Debt / FCF Ratio	0.07	0.07	-0.53	-0.69	-1.38	0.11
Asset Turnover	4.40	2.00	1.95	1.66	1.55	1.56
Quick Ratio	0.91	0.91	0.88	0.56	0.83	1.06
Current Ratio	0.96	0.96	0.94	0.63	0.90	1.13
Return on Equity (ROE)	-57.77%	-29.97%	503.05%	-532.46%	-77.70%	6.63%
Return on Assets (ROA)	-10.68%	-4.86%	15.82%	-24.23%	-15.28%	1.81%
Return on Invested Capital (ROIC)	-49.27%	-75.89%	197.60%	-190.03%	-84.03%	5.21%
Return on Capital Employed (ROCE)	-32.26%	-14.65%	69.61%	-85.69%	-34.49%	3.54%
Earnings Yield	-	-	4.62%	-	-	0.52%
FCF Yield	-	-	7.10%	-	1.65%	3.96%
Buyback Yield / Dilution	3.04%	3.04%	-5.31%	-0.04%	4.37%	2.84%
Total Shareholder Return	3.04%	3.04%	-5.31%	-0.04%	4.37%	2.84%

SEC Filings: 10-K · 10-Q